Medical ethicist David J. Alfandre, MD, MS, addresses the quandary of deciding who gets priority in the allocation of healthcare resources, an issue of particular relevance today now that COVID-19 vaccinations are underway.
Monisha Sharma, PhD, and Charlene Dewey, MD, provide insight into the current landscape that leads to physician burnout and the next steps to combat it.
The American Gastroenterological Association commissioned an expert review to identify best practice advice for treating patients with nonalcoholic fatty liver disease.
In September, as doctors prepared for a fall and winter COVID-19 surge across the U.S., they sounded alarms about inadequate supplies of the antiviral medication remdesivir to treat their patients. But that supply concern seems to have been addressed: Gilead, remdesivir’s U.S. manufacturer, confirmed that they are “meeting real-time, global demand” in an email to…
Although the emergence of COVID-19 initially called the continuation of inflammatory bowel disease (IBD) therapy into question, treatment has proceeded — albeit with added considerations.
The US Department of Health and Human Services’ Office for Civil Rights has levied big fines against medical organizations who failed to adhere to HIPAA requirements to release medical records to patients at their request.
Phase 2 clinical trial shows promising result for dabrafenib and trametinib combination in patients with advanced cholangiocarcinoma with a BRAFV600E mutation.